详情页 - 云南省第一人民医院机构库

当前位置：首页 > 详情页

PGM1 and ENO1 Promote the Malignant Progression of Bladder Cancer via Comprehensive Analysis of the m6A Signature and Tumor Immune Infiltration.

60| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Institute of Laboratory Medicine, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. [2]Institute of Laboratory Medicine, The First People's Hospital of Yunnan Province, Kunming 650000, Yunnan, China. [3]Kunming Medical University, Faculty of Medical Laboratory Science, The Third Affiliated Hospital of Kunming University, Kunming 650000, Yunnan, China. [4]Department of Neurology, Affiliated Hospital of North Sichuan Medical College, Institute of Neurological Diseases, North Sichuan Medical College, Nanchong 637000, Sichuan, China. [5]Department of Clinical Laboratory, 920th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army, Kunming 650000, Yunnan, China.

出处：

DOI：

ISSN：

摘要：

While N6-methyladenosine (m6A) modification of RNA and the tumor immune microenvironment both influence the progression of cancer, little attention has been paid to interactions between these two factors. Thus, we systematically explored potential biomarkers in the malignant progression of bladder urothelial carcinoma (BLCA) via combining expression of m6A methylation regulators with tumor immune infiltration.We extracted m6A regulators from published literature, downloaded BLCA RNA-seq and clinical information from the Cancer Genome Atlas database, and integrated three main bioinformatic methods and qPCR to explore the biological variations in the malignant progression of BLCA.FTO, IGF2BP3, and YTHDC1 have a significant difference in bladder cancer and prognosis. Two subgroups (clusters 1 and 2) were identified according to three key m6A regulators; cluster 1 was preferentially associated with poor prognosis and immune infiltration relative to cluster 2 significantly. We further identified PGM1 and ENO1 as potential prognostic biomarkers, as they were correlated with FTO and IGF2BP3 positively but with YTHDC1, negatively. M2 macrophage and TFH cells were highly infiltrated in BLCA and were associated with BLCA prognosis. Finally, PGM1 and ENO1 were correlated with M2 macrophage and TFH cells and their surface markers CD163and CXCR5.PGM1 and ENO1 are highly correlated with the malignant progression of BLCA, and the expression of these genes may be new indicators for the diagnosis and prognosis of BLCA.Copyright © 2022 Jinglin Zhao et al.

基金：

语种：

被引次数：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2022]版：

大类 | 3 区医学

小类 | 4 区肿瘤学

最新[2023]版：

无

JCR分区：

出版当年[2021]版：

Q2 ONCOLOGY

最新[2023]版：

无

影响因子： 0 最新[2023版] 0 最新五年平均 4.501 出版当年[2021版] 4.463 出版当年五年平均 4.375 出版前一年[2020版]

第一作者：

第一作者机构： [1]Institute of Laboratory Medicine, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. [2]Institute of Laboratory Medicine, The First People's Hospital of Yunnan Province, Kunming 650000, Yunnan, China.

共同第一作者：

通讯作者：

通讯机构： [1]Institute of Laboratory Medicine, The Affiliated Hospital of Kunming University of Science and Technology, Kunming, China. [2]Institute of Laboratory Medicine, The First People's Hospital of Yunnan Province, Kunming 650000, Yunnan, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：